News in brief: Cann Group; Vitura Health by Martin Lane November 27, 2024April 11, 2025 National Australia Bank (NAB) has agreed to defer A$900k in quarterly interest and facility fees for […]
News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024April 11, 2025
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
Cann Group faces more questions after reporting a bank balance of -$18,000 by Steve Jones October 23, 2024October 23, 2024
Cann Group cites positive press coverage as possible reason for share price surge by Martin Lane September 30, 2024January 13, 2025
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024January 13, 2025
Cann Group confirms Jenni Pilcher as MD and CEO after drawing up ‘well-defined strategy’ by Steve Jones July 18, 2024November 25, 2024
Cann Group secures additional funding, reissues half-year results by Steve Jones May 9, 2024July 16, 2024
